leon-nanodrugs GmbH (“LEON”), the main enabler of nano know-how for the pharmaceutical business, introduced at present the appointment of Dr. Hans Frickel as CEO, efficient July 1, 2023.
Dr. Hans Frickel, a educated pharmacist and industrial supervisor, brings greater than 20 years of expertise in strategic and operational management roles throughout all the worth chain of prescribed drugs and medical gadgets. Previous to becoming a member of LEON, he served as Managing Director at R‑Biopharm and held a number of senior operational administration roles at BioNTech, Evonik, Midas Pharma, Procter & Gamble and Merck.
Dr. Hubert Birner, Chairman of the LEON Supervisory Board, mentioned: “On behalf of the Supervisory Board, I’m delighted to welcome Dr. Hans Frickel to LEON. Together with his in depth experience in numerous areas of contemporary drug manufacturing, together with plant administration and QC, in addition to a powerful monitor file in technique and governance, he is a perfect match to take LEON to the following stage. On behalf of the Supervisory Board I additionally wish to thank our interim CEO and CFO Christian Nafe, our CSO Dr. Setu Kasera and their crew for his or her great work in driving our know-how in direction of commercialization and for the nice progress that has been achieved so far.”
“I’m excited to hitch LEON as we work to rework nanomedicine manufacturing,” mentioned Dr. Hans Frickel, CEO of LEON. “I’m impressed with the crew’s information and dedication in working to create added worth throughout the nano formulation processing chain. I actually consider that LEON’s NANO gadgets will considerably enhance growth and manufacturing for present and future standardized and customized cell & gene therapies at CDMOs, biotech and pharma firms.”
Supply: https://leon-nanodrugs.com/
